This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Transducin 3D structures
From Proteopedia
(Difference between revisions)
| Line 12: | Line 12: | ||
**[[1fqk]] – bTDN + RGS9 + GDP + AlF4<br /> | **[[1fqk]] – bTDN + RGS9 + GDP + AlF4<br /> | ||
**[[1fqj]] – bTDN + RGS9 + GMP-PDE γ + GDP + AlF4<br /> | **[[1fqj]] – bTDN + RGS9 + GMP-PDE γ + GDP + AlF4<br /> | ||
| + | **[[7jsn]] – bTDN (mutant) + phosphodiesterase + GTP + Levitra – Cryo EM<br /> | ||
*Transducin-β | *Transducin-β | ||
| Line 19: | Line 20: | ||
*Transducin-βγ | *Transducin-βγ | ||
| - | **[[5he0]], [[5he1]], [[5he2]], [[5he3]], [[5ukk]], [[5ukl]], [[5ukm]] – hTDN + β-adrenergic receptor kinase 1 + inhibitor<br /> | + | **[[5he0]], [[5he1]], [[5he2]], [[5he3]], [[5ukk]], [[5ukl]], [[5ukm]], [[7k7z]], [[7k7l]] – hTDN + β-adrenergic receptor kinase 1 + inhibitor<br /> |
**[[4kfm]] – hTDN + G-protein activated inward rectifier K+ channel<br /> | **[[4kfm]] – hTDN + G-protein activated inward rectifier K+ channel<br /> | ||
**[[6m8s]] – hTDN + KCTD12<br /> | **[[6m8s]] – hTDN + KCTD12<br /> | ||
| Line 29: | Line 30: | ||
**[[3v5w]] – bTDN (mutant) + G-protein coupled receptor kinase 2<br /> | **[[3v5w]] – bTDN (mutant) + G-protein coupled receptor kinase 2<br /> | ||
**[[3psc]], [[3pvu]], [[3pvw]], [[4mk0]] – bTDN + β-adrenergic receptor kinase 1<br /> | **[[3psc]], [[3pvu]], [[3pvw]], [[4mk0]] – bTDN + β-adrenergic receptor kinase 1<br /> | ||
| + | **[[6u7c]], [[6c2y]], [[5ukk]], [[5ukl]], [[5ukm]] – bTDN + β-adrenergic receptor kinase 1 + inhibitor<br /> | ||
**[[2bcj]] – bTDN (mutant) + β-adrenergic receptor kinase 1<br /> | **[[2bcj]] – bTDN (mutant) + β-adrenergic receptor kinase 1<br /> | ||
**[[3uzs]] – bTDN + β-adrenergic receptor kinase 1 + RNA<br /> | **[[3uzs]] – bTDN + β-adrenergic receptor kinase 1 + RNA<br /> | ||
| Line 35: | Line 37: | ||
**[[6pcv]] – bTDN + RAC exchanger – Cryo EM<br /> | **[[6pcv]] – bTDN + RAC exchanger – Cryo EM<br /> | ||
**[[6b20]] – bTDN + nanobody<br /> | **[[6b20]] – bTDN + nanobody<br /> | ||
| + | **[[6rmv]] – mTDN + channel peptide<br /> | ||
*Transducin-α+βγ | *Transducin-α+βγ | ||
| Line 51: | Line 54: | ||
**[[5tdh]] – h/r/bTDN (mutant) + GDP<br /> | **[[5tdh]] – h/r/bTDN (mutant) + GDP<br /> | ||
| - | *Transducin-α+βγ complex with antibody | + | *Transducin-α+βγ ternary complex with antibody |
**[[6pt0]], [[6n4b]], [[6kpg]], [[6kpf]] – hTDN + cannaboid receptor + antibody fragment – Cryo EM<br /> | **[[6pt0]], [[6n4b]], [[6kpg]], [[6kpf]] – hTDN + cannaboid receptor + antibody fragment – Cryo EM<br /> | ||
| - | **[[6pb1]], [[6pb0]] – hTDN + CRFR-2 + urocortin + nanobody – Cryo EM<br /> | ||
| - | **[[6os9]] – hTDN + NTR1 + JMV449 + antibody fragment – Cryo EM<br /> | ||
**[[6oik]], [[6oij]] – hTDN + AChR + antibody fragment – Cryo EM<br /> | **[[6oik]], [[6oij]] – hTDN + AChR + antibody fragment – Cryo EM<br /> | ||
| - | **[[6crk]] – hTDN + | + | **[[6crk]] – hTDN + scFv <br /> |
| - | **[[ | + | **[[6vms]] – r/hTDN + dopamine receptor + scFv <br /> |
| - | + | ||
**[[6ni3]] – hTDN + endolysin/adrenergic receptor + nanobody – Cryo EM<br /> | **[[6ni3]] – hTDN + endolysin/adrenergic receptor + nanobody – Cryo EM<br /> | ||
| - | **[[ | + | **[[6k41]], [[6k42]] – hTDN + adrenergic receptor + scFv – Cryo EM<br /> |
| - | **[[6p9y]] – hTDN + PACAP + nanobody – Cryo EM<br /> | + | **[[6wwz]] – hTDN + chemokine receptor + scFv – Cryo EM<br /> |
| + | **[[6wha]] – hTDN + hydroxytryptamine receptor + scFv – Cryo EM<br /> | ||
| + | **[[6xbk]], [[6xbj]], [[6xbl]], [[6xbm]] – hTDN + smoothened homolog + scFv – Cryo EM<br /> | ||
| + | **[[6ot0]] – hTDN + antibody + smoothened homolog – Cryo EM<br /> | ||
| + | **[[6p9y]], [[6lpb]], [[6m1i]] – hTDN + PACAP + nanobody – Cryo EM<br /> | ||
**[[6li3]] – hTDN + GPR52 + nanobody – Cryo EM<br /> | **[[6li3]] – hTDN + GPR52 + nanobody – Cryo EM<br /> | ||
**[[6gdg]] – hTDN + adenosine A2A receptor + nanobody – Cryo EM<br /> | **[[6gdg]] – hTDN + adenosine A2A receptor + nanobody – Cryo EM<br /> | ||
| - | **[[ | + | **[[7bw0]], [[7cfm]], [[7cfn]] – hTDN + bile acid receptor + nanobody – Cryo EM<br /> |
| - | **[[ | + | **[[5uz7]] – hTDN + calcitonin receptor + nanobody – Cryo EM<br /> |
| + | **[[7c2e]] – hTDN + glucagon receptor + nanobody – Cryo EM<br /> | ||
| + | **[[7d7m]] – hTDN + prostaglandin receptor + nanobody – Cryo EM<br /> | ||
| + | **[[7bz2]] – h/bTDN + adrenergic receptor + nnobody – Cryo EM<br /> | ||
**[[6cmo]] – hTDN + antibody + rhodopsin/cytochrome b562 – Cryo EM<br /> | **[[6cmo]] – hTDN + antibody + rhodopsin/cytochrome b562 – Cryo EM<br /> | ||
| - | **[[6qno]] – h/bTDN + antibody + rhodopsin + retinal – Cryo EM<br /> | ||
| - | **[[5vai]] – h/r/bTDN + glucagon-like peptide + antibody fragment - Cryo EM<br /> | ||
**[[3sn6]] – TDN ba (mutant) + rb (mutant) + bc + endolysine + antibody fragment<br /> | **[[3sn6]] – TDN ba (mutant) + rb (mutant) + bc + endolysine + antibody fragment<br /> | ||
| + | **[[7jjo]] – bTDN + adrenergic receptor + nanobody – Cryo EM<br /> | ||
| + | |||
| + | *Transducin-α+βγ quaternary complex with antibody | ||
| + | |||
| + | **[[6pb1]], [[6pb0]] – hTDN + CRFR-2 + urocortin + nanobody – Cryo EM<br /> | ||
| + | **[[6os9]] – hTDN + NTR1 + JMV449 + scFv – Cryo EM<br /> | ||
| + | **[[6niy]], [[6e3y]] – hTDN + calcitonin receptor + calcitonin + nanobody – Cryo EM<br /> | ||
| + | **[[6lfm]], [[6lfo]] – hTDN + chemokine receptor + IL8 + scFv – Cryo EM<br /> | ||
| + | **[[6omm]] – hTDN + formyl peptide receptor + peptide agonist + scFv – Cryo EM<br /> | ||
| + | **[[6vn7]] – hTDN + VIP-1 receptor + PACAP + nanobody – Cryo EM<br /> | ||
| + | **[[6m1h]] – hTDN + PAC1 receptor + maxadilan + nanobody – Cryo EM<br /> | ||
| + | **[[7d3s]], [[6wi9]], [[6wzg]] – hTDN + secretin receptor + secretin + nanobody – Cryo EM<br /> | ||
| + | **[[6whc]] – hTDN + glucagon receptor + dual-agonist peptide + nanobody – Cryo EM<br /> | ||
| + | **[[6lmk]], [[6lml]], [[6x1a]], [[6x19]], [[6x18]], [[6wpw]], [[5vai]], [[6vcb]] – hTDN + glucagon receptor + glucagon + nanobody – Cryo EM<br /> | ||
| + | **[[7cz5]] – hTDN + growth hormone-releasing hormone receptor + somatoliberin + nanobody – Cryo EM<br /> | ||
| + | **[[6uva]], [[6uun]], [[6uus]] – hTDN + receptor activity-modifying protein + ADM2 + CGRP receptor + nanobody – Cryo EM<br /> | ||
| + | **[[6b3j]] – hTDN + GLP-1R + exendin-p5 + nanobody – Cryo EM<br /> | ||
| + | **[[6qno]] – h/bTDN + antibody + rhodopsin + retinal – Cryo EM<br /> | ||
}} | }} | ||
[[Category: Topic Page]] | [[Category: Topic Page]] | ||
Revision as of 10:54, 13 December 2020
3D structures of transducin
Updated on 13-December-2020 - For a general description of the protein see Transducin
